Cardiology is now entering the same outpatient migration curve that orthopedics and gastroenterology experienced over the past decade. Growth data from 2025 and early 2026 shows outpatient cardiovascular procedures expanding at rates exceeding 15 percent annually, making it one of the fastest growing segments within the ASC environment.

Diagnostic cardiac catheterization has already crossed a meaningful threshold, with more than 45 percent of procedures performed outside hospital settings in certain markets. Electrophysiology is following closely. Ablation procedures, particularly for atrial fibrillation, are moving into outpatient environments with reported growth rates of 20 to 25 percent annually in early adopting centers.

The financial drivers are obvious. Hospital based cardiac procedures typically range from $18,000 to $32,000 per case. Equivalent procedures in outpatient settings are often delivered between $8,000 and $18,000, producing cost reductions of 30 to 50 percent. Employers and payers are increasingly designing benefit structures that steer patients toward these lower cost sites of care.

Clinical outcomes are supporting the shift. Recent studies demonstrate complication rates below 1 percent for outpatient diagnostic catheterization, with same day discharge rates exceeding 90 percent in appropriately selected patients. Advances in radial access and anticoagulation management have further reduced procedural risk.

The barrier remains infrastructure. Cardiology capable ASCs require significant investment in imaging platforms, specialized personnel, emergency transfer protocols, and enhanced recovery systems. Equipment costs alone frequently fall between $800,000 and $1.5 million.

Despite these barriers, margins are attractive. Contribution margins ranging from $2,000 to $5,000 per case are achievable depending on case complexity and payer mix.

The long term trajectory is clear. While structural heart interventions remain hospital based for now, incremental migration is expected as technology, protocols, and payer acceptance evolve.

Cardiology is no longer a distant opportunity. It is an active expansion pathway. The centers that build capability early will define the economics of this transition.